​

Vera Therapeutics Ownership | Who Owns Vera Therapeutics?

OverviewForecastFinancialsChart

Vera Therapeutics Ownership Summary

Vera Therapeutics is owned by 112.46% institutional investors, 0.88% insiders. Avoro capital advisors is the largest institutional shareholder, holding 9.17% of VERA shares. State Street® SPDR® S&P® Biotech ETF is the top mutual fund, with 2.97% of its assets in Vera Therapeutics shares.

VERA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockVera Therapeutics112.46%0.88%-13.33%
SectorHealthcare Stocks 35.71%11.88%52.42%
IndustryBiotech Stocks 35.98%11.86%52.17%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Avoro capital advisors5.89M9.17%$236.91M
Blackrock funding, inc. /de5.09M7.92%$204.69M
Price t rowe associates inc /md/4.57M7.12%$184.01M
Blackrock3.34M6.55%$120.76M
Deep track capital, lp4.11M6.39%$165.19M
Deerfield management company, l.p. (series c)3.72M5.79%$149.74M
Vanguard group3.57M5.59%$180.81M
Kynam capital management, lp3.40M5.29%$136.71M
State street3.36M5.24%$135.32M
Sofinnova investments2.79M4.35%$112.40M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Kynam capital management, lp3.40M8.43%$136.71M
Tri locum partners lp1.19M7.95%$34.59M
Eversept partners, lp2.17M4.61%$87.43M
Portman32.80K4.48%$1.19M
Sofinnova investments2.79M4.27%$112.40M
Integral health asset management1.60M3.08%$64.37M
Deep track capital, lp4.11M2.70%$165.19M
Bioimpact capital563.08K2.68%$16.36M
Exome asset management114.99K2.39%$4.63M
Avoro capital advisors5.89M2.33%$236.91M

Top Buyers

HolderShares% AssetsChange
Deep track capital, lp4.11M2.70%1.28M
Vestal point capital, lp1.37M1.54%818.16K
Tri locum partners lp1.19M7.95%777.09K
State street3.36M0.00%687.04K
Schroder investment management group484.38K0.02%452.60K

Top Sellers

HolderShares% AssetsChange
T. rowe price investment management---1.68M
Paradigm biocapital advisors lp---1.44M
Holocene advisors, lp---1.31M
Samlyn capital---978.42K
Eversept partners, lp2.17M4.61%-899.02K

New Positions

HolderShares% AssetsChangeValue
Vanguard fiduciary trust441.51K0.00%441.51K$17.76M
Hsbc297.02K0.00%297.02K$8.63M
Axa investment managers229.64K0.02%229.64K$6.67M
Ikarian capital200.00K0.65%200.00K$8.05M
Great point partners199.35K1.84%199.35K$8.02M

Sold Out

HolderChange
Coldstream capital management-6.00
Geowealth management-6.00
Nelson, van denburg & campbell wealth management group-7.00
Bare financial services-9.00
Capital performance advisors llp-11.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20262376.28%72,234,406-2.40%1120.84%140-2.78%658.33%
Dec 31, 2025146-19.34%42,673,172-34.42%660.64%91-9.90%42-12.50%
Sep 30, 2025175-0.57%63,626,8635.34%991.11%96-6.80%46-2.13%
Jun 30, 20251840.55%63,880,1552.67%1001.05%1089.09%47-4.08%
Mar 31, 20251861.64%62,983,0820.11%980.75%101-20.47%5035.14%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
State Street® SPDR® S&P® Biotech ETF2.13M2.97%-21.07K
Vanguard Total Stock Mkt Idx Inv1.91M2.66%6.72K
Fidelity Growth Compy Commingled Pl O1.16M2.11%-
Vanguard US Total Market Shares ETF1.33M2.09%-2.90K
iShares Russell 2000 ETF1.45M2.02%12.22K
T. Rowe Price Health Sciences1.32M1.83%-123.81K
Fidelity Growth Compy Commingled Pl S1.20M1.68%1.47K
T. Rowe Price New Horizons1.12M1.57%-10.03K
US Small-Cap Growth II Equity Comp1.12M1.57%-11.19K
SPDR® S&P Biotech ETF878.00K1.38%1.96K

Recent Insider Transactions

DateNameRoleActivityValue
May 12, 2026Fordyce Marshall PRESIDENT AND CEOSell$158.77K
May 12, 2026Fordyce Marshall PRESIDENT AND CEOSell$520.98K
Apr 14, 2026Fordyce Marshall PRESIDENT AND CEOSell$353.11K
Apr 14, 2026Fordyce Marshall PRESIDENT AND CEOSell$40.96K
Apr 14, 2026Fordyce Marshall PRESIDENT AND CEOSell$616.99K

Insider Transactions Trends

DateBuySell
2026 Q2-5
2026 Q1-7
2025 Q415
2025 Q24-
2025 Q1-6

VERA Ownership FAQ

Who Owns Vera Therapeutics?

Vera Therapeutics shareholders are primarily institutional investors at 112.46%, followed by 0.88% insiders and -13.34% retail investors. The average institutional ownership in Vera Therapeutics's industry, Biotech Stocks , is 35.98%, which Vera Therapeutics exceeds.

Who owns the most shares of Vera Therapeutics?

Vera Therapeutics’s largest shareholders are Avoro capital advisors (5.89M shares, 9.17%), Blackrock funding, inc. /de (5.09M shares, 7.92%), and Price t rowe associates inc /md/ (4.57M shares, 7.12%). Together, they hold 24.21% of Vera Therapeutics’s total shares outstanding.

Does Blackrock own Vera Therapeutics?

Yes, BlackRock owns 6.55% of Vera Therapeutics, totaling 3.34M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 120.76M$. In the last quarter, BlackRock increased its holdings by 18.71K shares, a 0.56% change.

Who is Vera Therapeutics’s biggest shareholder by percentage of total assets invested?

Kynam capital management, lp is Vera Therapeutics’s biggest shareholder by percentage of total assets invested, with 8.43% of its assets in 3.4M Vera Therapeutics shares, valued at 136.71M$.

Who is the top mutual fund holder of Vera Therapeutics shares?

State Street® SPDR® S&P® Biotech ETF is the top mutual fund holder of Vera Therapeutics shares, with 2.97% of its total shares outstanding invested in 2.13M Vera Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools